Literature DB >> 10669645

Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions.

A Ravandi1, A Kuksis, N A Shaikh.   

Abstract

Glycation of both protein and lipid components is believed to be involved in LDL oxidation. However, the relative importance of lipid and protein glycation in the oxidation process has not been established, and products of lipid glycation have not been isolated. Using glucosylated phosphatidylethanolamine (Glc PtdEtn) prepared synthetically, we have identified glycated diacyl and alkenylacyl species among the ethanolamine phospholipids in LDL. Accumulation of these glycation products in LDL incubated with glucose showed a time- and glucose concentration-dependent increase. LDL specifically enriched with Glc PtdEtn (25 nmol/mg protein) showed increased susceptibility to lipid oxidation when dialyzed against a 5-micromol/L Cu(2+) solution. The presence of this glucosylated lipid resulted in a 5-fold increase in production of phospholipid-bound hydroperoxides and 4-fold increase in phospholipid-bound aldehydes. Inclusion of glucosylated phosphatidylethanolamine in the surface lipid monolayer of the LDL resulted in rapid loss of polyunsaturated cholesteryl esters from the interior of the particle during oxidation. Glycated ethanolamine phospholipids were also isolated and identified from atherosclerotic plaques collected from both diabetic and nondiabetic subjects. The present findings provide direct evidence for the previously proposed causative effect of lipid glycation on LDL oxidation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669645     DOI: 10.1161/01.atv.20.2.467

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

2.  Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.

Authors:  Phumon Sookwong; Kiyotaka Nakagawa; Ikuko Fujita; Naoki Shoji; Teruo Miyazawa
Journal:  Lipids       Date:  2011-07-06       Impact factor: 1.880

3.  LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.

Authors:  Naoki Shoji; Kiyotaka Nakagawa; Akira Asai; Ikuko Fujita; Aya Hashiura; Yasushi Nakajima; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

4.  Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.

Authors:  Kerri J Grove; Paul A Voziyan; Jeffrey M Spraggins; Suwan Wang; Paisit Paueksakon; Raymond C Harris; Billy G Hudson; Richard M Caprioli
Journal:  J Lipid Res       Date:  2014-05-26       Impact factor: 5.922

5.  The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients.

Authors:  S Braschi; M Geoffrion; A Nguyen; Y Gaudreau; R W Milne
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

6.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

7.  Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?

Authors:  M Du; M Wu; D Fu; S Yang; J Chen; K Wilson; T J Lyons
Journal:  Diabetologia       Date:  2013-07-11       Impact factor: 10.122

Review 8.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

Review 9.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

Review 10.  Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside.

Authors:  Alexandre Mezentsev; Evgeny Bezsonov; Dmitry Kashirskikh; Mirza S Baig; Ali H Eid; Alexander Orekhov
Journal:  Biomedicines       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.